{"filing":{"accession_number":"0001723464-26-000036","cik":"0001723464","ticker":"BHST","company_name":"BIOHARVEST SCIENCES INC.","form":"6-K","filing_date":"2026-07-15","report_date":null,"primary_document":"bhsc_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1723464/000172346426000036/bhsc_6k.htm"},"events":[{"id":18105,"run_id":16258,"accession_number":"0001723464-26-000036","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"BioHarvest announced receipt of a $1.4 million non-dilutive grant from the Israel Innovation Authority to fund a research initiative integrating AI and machine learning into its plant-cell synthesis development workflows. This is a material operational and strategic event—the grant supports core R\u0026D capabilities and represents the company's second IIA grant this year—but does not fit the specific categories of debt issuance, equity dilution, or M\u0026A activity. The funding is non-dilutive and structured as a zero-interest loan contingent on commercial milestones, making it a significant operational development rather than a financial obligation or capital raise.","company_name":"BIOHARVEST SCIENCES INC.","ticker":"BHST","filing_date":"2026-07-15","form":"6-K","submitted_at":null,"items":[{"id":16812,"accession_number":"0001723464-26-000036","item_number":"EX-99.1","item_title":"bhsc_ex991.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"BioHarvest announced receipt of a $1.4 million non-dilutive grant from the Israel Innovation Authority to fund a research initiative integrating AI and machine learning into its plant-cell synthesis development workflows. This is a material operational and strategic event—the grant supports core R\u0026D capabilities and represents the company's second IIA grant this year—but does not fit the specific categories of debt issuance, equity dilution, or M\u0026A activity. The funding is non-dilutive and structured as a zero-interest loan contingent on commercial milestones, making it a significant operational development rather than a financial obligation or capital raise.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-15T19:25:38.351835+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16812,"accession_number":"0001723464-26-000036","item_number":"EX-99.1","item_title":"bhsc_ex991.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"BioHarvest announced receipt of a $1.4 million non-dilutive grant from the Israel Innovation Authority to fund a research initiative integrating AI and machine learning into its plant-cell synthesis development workflows. This is a material operational and strategic event—the grant supports core R\u0026D capabilities and represents the company's second IIA grant this year—but does not fit the specific categories of debt issuance, equity dilution, or M\u0026A activity. The funding is non-dilutive and structured as a zero-interest loan contingent on commercial milestones, making it a significant operational development rather than a financial obligation or capital raise.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-15T19:25:38.351835+00:00","company_name":"BIOHARVEST SCIENCES INC.","ticker":"BHST","filing_date":"2026-07-15"}]}